Skip to main content

The Weight Loss Drug Gold Mine

U.S. healthcare providers wrote more than 9 million prescriptions for GLP-1 drugs in the final quarter of 2022, as demand soared for the blockbuster treatments. And one key company is reaping the benefits.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.